CommercialCoverageMedium impact
11.17.06v, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
Medical necessity criteria for surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH) have been updated. This policy change affects urology procedures and billing requirements for BPH treatments.
Action Required
Before July 28, 2025: Billing team and providers must review updated medical necessity criteria for BPH surgical treatments. Update documentation requirements in EMR templates to ensure compliance with new criteria. Verify pre-authorization requirements align with updated policy to prevent claim denials.